Wei, Hong
Zheng, Tianying
Zhang, Xiaolan
Zheng, Chao
Jiang, Difei
Wu, Yuanan
Lee, Jeong Min
Bashir, Mustafa R.
Lerner, Emily
Liu, Rongbo
Wu, Botong
Guo, Hua
Chen, Yidi
Yang, Ting
Gong, Xiaoling
Jiang, Hanyu
Song, Bin http://orcid.org/0000-0002-7269-2101
Funding for this research was provided by:
National Natural Science Foundation of China (82101997, 82101997, 82101997, 82101997, 82101997, 82101997)
the China Postdoctoral Science Foundation (2023T160448)
Article History
Received: 16 January 2024
Revised: 15 May 2024
Accepted: 16 June 2024
First Online: 19 July 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Bin Song, M.D.
: H.W.: no relevant relationships. T.Z.: no relevant relationships. X.Z., C.Z., and D.J.: employees of Shukun Technology Co., Ltd. Y.W.: no relevant relationships. J.M.L.: no relevant relationships. M.R.B.: research grants to the institution from Siemens Healthineers, Madrigal Pharmaceuticals, NGM Biopharmaceuticals, Carmot Therapeutics, and Corcept Therapeutics; associate editor for contrast media section of Radiology; associate editor for continuing medical education of Journal of Magnetic Resonance Imaging. E.L.: no relevant relationships. R.L.: no relevant relationships. B.W.: no relevant relationships. H.G.: no relevant relationships. Y.C.: no relevant relationships. T.Y.: no relevant relationships. X.G.: no relevant relationships. H.J.: stock owner of Kanghong Technology Co., Ltd. B.S.: no relevant relationships.
: One co-author (Yuanan Wu, Big Data Research Center, University of Electronic Science and Technology of China, Chengdu, Sichuan 610000, China) has significant statistical expertise.
: The requirement for informed consent was waived (retrospective design) by the Biomedical Ethics Review Committee of West China Hospital, Sichuan University.
: The study protocol was approved by the Biomedical Ethics Review Committee of West China Hospital, Sichuan University (Approval Numbers: 2022-651).
: Some study subjects (37.5%, 222/592) have been previously reported in another study. While the prior work proposed a preoperative prognostic score for overall survival, the current work focused on exploring three-dimensional quantitative tumor burden biomarkers for predicting postsurgical early recurrence of hepatocellular carcinoma.
: